At the 20 drops per millilitre convention these products use, one drop of a 1% solution is about 0.5 mg, so roughly two drops is 1 mg. That is the arithmetic, and it is the easy part. The harder question is how much is right for you, and that has a different kind of answer.
Key takeaways
- One drop of a 1% solution is about 0.5 mg. Two drops is roughly 1 mg. A 0.5% solution is half that strength.
- A “drop” is a convention, not a measurement. Its size changes with the dropper tip, the angle you hold it at, and how fast you squeeze.
- Published human studies have used amounts from 15 mg to 260 mg, but almost all were single occasions in small groups, not daily use.
- There is no official daily amount for everyday use, which is why every chart online gives a different number.
- Methylene blue is a potent monoamine oxidase inhibitor. Combined with common antidepressants it can cause serotonin syndrome, and the FDA has issued a specific warning about this.
- It should not be used by people with G6PD deficiency, or during pregnancy or breastfeeding.
How many drops of methylene blue is 1 mg?
This one can be answered with arithmetic, and the arithmetic is worth seeing for yourself.
Step one, concentration. A 1% solution means 1 gram in 100 millilitres, which works out to 10 mg per millilitre. This is confirmed on an actual consumer methylene blue label filed in the FDA’s labelling database. (DailyMed) A 0.5% solution is half that, 5 mg per millilitre.
Step two, drops per millilitre. That same label tells users to “mix 1 ml (20 drops) of the solution with 200 ml of water,” so the product itself treats 20 drops as one millilitre.
Step three, the maths.
| Concentration | Per mL | Per drop, at 20 drops/mL | Drops for 1 mg |
|---|---|---|---|
| 1% | 10 mg | about 0.5 mg | about 2 drops |
| 0.5% | 5 mg | about 0.25 mg | about 4 drops |
So the short answer most people are looking for is about two drops of a 1% solution for 1 mg.
Now the part that matters more than the answer itself.
Why a drop is not really a measurement
Twenty drops per millilitre is a convention, not a physical constant.
Published pharmaceutical research on dropper bottles found that drop volume changes significantly depending on the design of the dropper tip, the angle you hold it at, and how fast you squeeze. A wetted rubber tip produced what the researchers described as a dramatic increase in drop size. Even under tightly controlled laboratory conditions with plastic tips held perfectly upright, there was still measurable variation, and that was the best case rather than the typical one. (Sklubalová and Zatloukal, Pharmazie 2005)
In plain terms: two people counting the same number of drops from two different bottles are not taking the same amount. Neither is the same person on a rushed morning versus a slow evening, or with a bottle that is nearly full versus nearly empty.
This is the real problem with every “take X drops daily” instruction online. Even if the number happened to be right for you, the unit cannot deliver it reliably. Your count can be correct and your amount still wrong.
Liquid and dropper, or a fixed dose?
These are the two forms you will come across, and the difference is not cosmetic.
With a liquid and a dropper, you are measuring every single time you take it, with all the variability described above.
With a fixed dose form, such as a capsule or tablet, the amount was decided once, by whoever prepared it, and it is the same every day. The clinical study described in the next section used capsules for exactly this reason: the researchers needed to know that every participant received 86.66 mg, not approximately that.
Neither form makes the substance itself safer or more effective. What changes is whether you are the one doing the measuring, and whether you can know afterwards what you actually took.
How much methylene blue per day?
Here is the honest answer: there is no official daily amount for everyday use. That is exactly why the numbers you find online contradict each other so badly. Each site picked one, and most do not say where it came from.
What can be described is what published human research has actually used. Read these as what was studied, not as what you should take.
What human studies have used
260 mg, once, split across a day. A trial in 42 adults with claustrophobia gave 260 mg of oral methylene blue as three capsules of 86.66 mg, the first immediately after a therapy session, the second at bedtime and the third on waking. The comparator was a true placebo, a blue food dye chosen so participants could not tell from their urine which they had taken. (Telch et al., American Journal of Psychiatry 2014)
The result is worth reading carefully, because it is not the story people expect. The effect depended on how the session had gone. Participants who finished training calm were less fearful a month later on methylene blue. Participants who finished training still frightened did worse on methylene blue than on placebo. The authors also note the memory benefit amounted to recalling roughly one extra item out of four.
15 mg against 195 mg, daily. A randomised crossover study in people with bipolar disorder compared these two amounts. The low amount was used as the comparator rather than an inert placebo, again because blue urine gives the game away. (Alda et al., British Journal of Psychiatry 2017)
A single low oral dose, brain imaging. A study in 26 healthy adults scanned participants before and one hour after a single low oral dose, reporting a 7% improvement on one laboratory memory task. The published abstract describes the amount only as “low-dose” and does not state it in milligrams. (Rodriguez et al., Radiology 2016)
Read those numbers with your eyes open
Four things before anyone treats the figures above as a target.
They are not daily wellness protocols. Two of the three were single occasions. None studied taking methylene blue every day for months.
The samples are tiny. Forty two people, twenty six people. These are early-stage studies, not the kind of evidence that settles a dose.
The comparator was often the same drug at a lower amount, not a true placebo, which makes the results harder to interpret than they first appear.
And the numbers move. A thirteen-fold gap inside one study, a 260 mg single day in another, and an unstated amount in a third. This is not a field that has converged on an answer. Any website presenting a confident daily figure has gone further than the evidence does.
What is documented at higher amounts
The clinical reference literature describes a window narrower than most people assume. At intravenous doses, methylene blue is generally well tolerated below 2 mg per kilogram of body weight. At single doses of 3 mg/kg or more, low blood pressure, wheezing and reduced oxygenation have been reported. At cumulative doses of 7 mg/kg or more: nausea, vomiting, chest pain, breathlessness, rapid heartbeat, tremor, dilated pupils and confusion, lasting two to twelve hours. At 20 mg/kg or more, severe destruction of red blood cells and death have occurred, and there is no specific antidote. (StatPearls, NIH Bookshelf)
Those are intravenous clinical figures and cannot be converted into drops at your kitchen table. They are here to show the shape of the risk, not to give you a target.
The interaction that matters most
If you read one section of this page, make it this one.
Methylene blue is a potent, reversible monoamine oxidase inhibitor. That is not a fringe claim, it is how the FDA describes it. In a Drug Safety Communication issued on 26 July 2011, the agency warned about serious central nervous system reactions when methylene blue is given to people taking serotonergic psychiatric medications. Reported reactions included lethargy, confusion, delirium, agitation, aggression and coma, alongside muscle jerking, seizures, fever and raised blood pressure. (FDA Drug Safety Communication)
The FDA’s own list of implicated medications covers drugs that millions of people take daily:
- SSRIs: sertraline, fluoxetine, paroxetine, citalopram, escitalopram, fluvoxamine
- SNRIs: venlafaxine, desvenlafaxine, duloxetine
- Tricyclics: amitriptyline, nortriptyline, imipramine, clomipramine and others
- MAOIs: phenelzine, selegiline, tranylcypromine, isocarboxazid
- Others: bupropion, buspirone, trazodone, mirtazapine, nefazodone, vilazodone
The pharmaceutical product’s labelling carries a boxed warning, the strongest warning the FDA issues, headed “Serotonin syndrome with concomitant use of serotonergic drugs and opioids,” and states the drug may cause serious or fatal serotonin syndrome. The labelling also advises avoiding serotonergic medications for at least 72 hours after the last dose. (DailyMed)
The FDA specifically noted that patients and even clinicians may not realise methylene blue has MAOI properties. If you take any antidepressant, this is not a detail to sort out later. It is the first thing to settle.
Who should not take methylene blue
G6PD deficiency. In people with glucose-6-phosphate dehydrogenase deficiency, methylene blue can cause severe destruction of red blood cells and severe anaemia. It also may not work as intended, because the body cannot convert it to its active form. Hemolysis can happen in people without the deficiency too, and the resulting anaemia can be delayed by a day or more. G6PD deficiency is common in people of African, Mediterranean, Middle Eastern and South Asian ancestry, and many who have it do not know.
Pregnancy. The labelling states methylene blue may cause fetal harm, and exposure near term can cause a range of newborn complications.
Breastfeeding. The labelling advises stopping breastfeeding during treatment and for up to eight days afterwards.
Anyone taking serotonergic medication or opioids, as covered above.
Where does methylene blue come from?
It started as a fabric dye.
Methylene blue was first synthesised in 1876, with commercial manufacture using dimethylaniline beginning around 1886. (Britannica) Its first job was colouring textiles.
Within a few years scientists noticed something more interesting: the dye stained microorganisms, which made it valuable for studying bacteria under a microscope. From staining bugs it was a short step to killing them. In 1891 it was found useful against malaria, and it is often described as the first synthetic compound used as an antiseptic in clinical therapy. (Harvard Health)
Since then it has served as an antimalarial, an antidote for cyanide poisoning, a surgical dye for mapping lymph nodes, and today it is used intravenously in hospitals to treat a blood disorder called acquired methemoglobinemia.
So when people say methylene blue has more than a century of history, that is true. The history, though, is of a hospital medicine and a laboratory stain. The history of taking it daily from a dropper bottle is about a decade old, and it is a much thinner story.
Where to buy methylene blue
There are four realistic routes, and they are not equivalent.
1. A pharmacy, on a prescription. A compounding pharmacy prepares it when a licensed prescriber writes for it. The amount is set for the individual and the preparation is made to that specification.
2. Through a telehealth provider. This is how most people reach the prescription route now. You complete a health intake online, a licensed provider reviews your history and your current medications, and if it is appropriate the pharmacy prepares it and ships it to you. The review happens before anything is dispensed, which is the part that matters given the interactions covered above.
3. Online wellness retailers. No provider is involved, nobody reviews what else you are taking, and the labelling is where the problems appear.
4. Chemical suppliers and aquarium shops. These products are not prepared for human use and are not intended for it.
The first two involve someone qualified checking whether this is appropriate for you before you take it. The second two do not, and the decision sits entirely with you.
What a consumer label actually looks like
One 1% product filed in the FDA’s labelling database lists its route of administration as extracorporeal, meaning outside the body, while its own directions tell you to mix it into 200 ml of water and drink it. The same label calls the product “a dietary supplement” while carrying an over-the-counter drug marketing category. Its stated purposes include “memory consolidation” and “mental fatigue resistance,” and the directions close with the phrase “or use according to your established research protocols.” (DailyMed)
One label contradicting itself three times. If a label cannot state plainly what the product is or how it is meant to enter your body, it is a poor basis for deciding what goes into yours.
What to check before buying anything
- Do you know the amount you are taking, in milligrams? Either the product states it, or a prescriber has set it for you. What you do not want is neither, which is what a dropper bottle with no milligram figure leaves you with.
- Does it state a grade? Published human research specifies USP grade. A product that does not say what grade it is has told you nothing about its purity.
- Does it say who made it and where?
- Does anyone mention the serotonergic drug interaction and G6PD deficiency? If a seller will not raise a boxed-warning-level interaction on something they want you to swallow daily, that tells you how much thought they have given your safety.
- Is a real person deciding whether this is appropriate for you, or is the entire process a checkout button?
If you are not sure, do not guess
Most people who land on this question are not trying to become experts in dropper physics. They want to know whether this is something they should take at all, and if so, how much.
That is a clinical question with a clinical answer. If you would rather have someone qualified look at your health history and your current medications and tell you straight, you can fill out a short health assessment here. A member of the health team goes through it with you and a licensed provider decides whether it is appropriate before anything is prescribed. Sometimes the answer is that it is not, and that is a real answer too.
So how many drops of methylene blue should you take?
Not a number this page can give you, and not one any page can.
The things that change the answer include your body weight, your kidney and liver function, whether you have G6PD deficiency, whether you are pregnant or breastfeeding, and above all everything else you are taking. The antidepressant interaction alone rules this out for a very large number of people, and no online chart can know whether you are one of them.
This is also why a known milligram matters more than a number of drops. An amount set for you by someone who has seen your full history is a different thing from counting drips from a bottle and hoping the dropper cooperates.
Frequently asked questions
How many drops of methylene blue should I take?
There is no established number, and any site that gives you one has chosen it themselves. The amount that suits one person does not suit another, and it depends most of all on what else you are taking.
How many drops of methylene blue is 1 mg?
At the 20 drops per millilitre convention products use, about two drops of a 1% solution, or about four drops of a 0.5% solution. Treat that as arithmetic rather than a dose, because real drop size varies with the dropper and how you use it.
How many mg of methylene blue per day?
No official figure exists for everyday use. Published studies have used 15 mg, 195 mg and 260 mg in different contexts, mostly on single occasions in groups of 26 to 42 people. That range shows how unsettled the area is rather than pointing to a number for you.
Where can I buy methylene blue?
Through a pharmacy on a prescription, through a telehealth provider who arranges the prescription and the pharmacy, from online wellness retailers where no provider is involved, or from chemical and aquarium suppliers whose products are not made for human use. The section above covers what separates them.
Where does methylene blue come from?
It was first synthesised in 1876 as a textile dye, was later used to stain microorganisms, was found useful against malaria in 1891, and is used in hospitals today for a blood disorder called methemoglobinemia.
Can I take methylene blue with an antidepressant?
Methylene blue is a potent MAO inhibitor, the FDA has issued a specific warning about combining it with SSRIs, SNRIs and other serotonergic medications, and the pharmaceutical labelling carries a boxed warning about serotonin syndrome. Speak to a clinician who can see your full medication list.
Why does methylene blue turn urine blue or green?
Because it is a dye and your body excretes it. It is expected, and it is also why researchers struggle to run a properly blinded placebo study on it.
This article is for general educational purposes and is not medical advice, diagnosis or treatment, and it does not create a provider patient relationship. It does not recommend a dose and should not be used to self-treat. Methylene blue is FDA-approved only as an intravenous treatment for acquired methemoglobinemia and is not FDA-approved for energy, focus, cognitive or longevity use. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness or quality. Individual results vary. Only a licensed healthcare provider who has reviewed your full medical history and current medications can determine whether any medication is appropriate for you. If you think you may be experiencing a medical emergency, call 911.
Sources: FDA Drug Safety Communication, 26 July 2011 · StatPearls, NIH Bookshelf · Prescribing information, DailyMed · Consumer product label, DailyMed · Telch et al., American Journal of Psychiatry 2014 · Alda et al., British Journal of Psychiatry 2017 · Rodriguez et al., Radiology 2016 · Sklubalová and Zatloukal, Pharmazie 2005 · Harvard Health · Britannica